L
Logeeshan Velmanickam
Researcher at North Dakota State University
Publications - 20
Citations - 119
Logeeshan Velmanickam is an academic researcher from North Dakota State University. The author has contributed to research in topics: Dielectrophoresis & Avidin. The author has an hindex of 7, co-authored 20 publications receiving 98 citations. Previous affiliations of Logeeshan Velmanickam include University of Moratuwa.
Papers
More filters
Journal ArticleDOI
Dielectrophoretic label-free immunoassay for rare-analyte quantification in biological samples.
TL;DR: A label-free, high-throughput technique capable of quantifying target analytes down to a few thousands of molecules (∼zmoles) is reported on, capable of detecting well below the current limit of the ELISA test.
Journal ArticleDOI
iLluminate-miRNA: Paradigm for high-throughput, low-cost, and sensitive miRNA detection in serum samples at point-of-care
Logeeshan Velmanickam,Manpreet Bains,Michael Fondakowski,Glenn Dorsam,Dharmakeerthi Nawarathna +4 more
Journal ArticleDOI
Negative dielectrophoresis spectroscopy for rare analyte quantification in biological samples.
Syed Abdul Mannan Kirmani,Fleming Dackson Gudagunti,Logeeshan Velmanickam,Dharmakeerthi Nawarathna,Ivan T. Lima +4 more
TL;DR: In this article, negative dielectrophoresis (DEP) spectroscopy was used to improve the detection limit of rare analytes in biological samples by observing a significant dependence of negative DEP force on functionalized polystyrene beads at the edges of interdigitated electrodes with respect to the frequency of the electric field.
Journal ArticleDOI
Integrated dielectrophoretic and surface plasmonic platform for million-fold improvement in the detection of fluorescent events
TL;DR: The results show that the DEP is capable of placing the fluorescent molecules on the hotspots, which is depicted as a significant reduction in the fluorescence lifetime of those molecules.
Journal ArticleDOI
Label-Free Biosensing Method for the Detection of a Pancreatic Cancer Biomarker Based on Dielectrophoresis Spectroscopy
TL;DR: Since negative DEP spectroscopy is an effective transduction mechanism for the detection of the cutoff levels of CA 19-9, it has the potential to be used in the early stage diagnosis and in the prognosis of pancreatic cancer.